Phase II study evaluating the role of exemestane [Aromasine] on clinical and pathologic response rates, and its aromatase activity as treatment in neoadjuvant setting for operable breast cancer patients.
Phase of Trial: Phase II
Latest Information Update: 21 Apr 2011
At a glance
- Drugs Exemestane (Primary)
- Indications Breast cancer
- Focus Therapeutic Use
- 16 Oct 2005 New trial record.